Faculty

Back to Index
Mojtaba Akhtari, MD
Associate Professor of Clinical Medicine
Medicine
1441 Eastlake Ave. Off Campus Los Angeles

Overview

Dr. Mojtaba Akhtari is an Associate Professor of Clinical Medicine at Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California USC Norris Cancer Center/Keck Medical Center of USC. Before joining USC he served as an Assistant Professor of Medicine at the Division of Hematology and Oncology, University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. He is a Hematologist/Oncologist with medical and hematology/oncology training and experience in United Kingdom and United States of America. Dr. Akhtari is board certified in Internal Medicine, Hematology and Medical Oncology.

His experience is fairly wide ranging having worked in academic teaching medical centers and community hospitals with high clinical workloads and a heavy reliance on clinical skills. He is also a member of adult bone marrow transplantation team at USC. He has authored several book chapters and many articles in peer-reviewed journals. He received Humanism in Medicine Award at St. Francis Hospital of Evanston, Illinois. He is an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Society for Blood and Marrow Transplantation (ASBMT).

Awards

Keck School of Medicine, Department of Medicine: Faculty Teaching Award, 2014-2015

St. Francis Hospital of Evanston, IL : Humanism in Medicine Award, 2007

Publications

. View in: PubMed

Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus. Lupus. 2016 Oct; 25(11):1244-53. View in: PubMed

Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia. Immunol Lett. 2016 Apr; 172:113-23. View in: PubMed

Monoclonal Antibodies and Immune Therapies for Adult Precursor B-Acute Lymphoblastic Leukemia. Immunol Lett. 2016 Feb 23. View in: PubMed

Emerging treatment options for myelofibrosis: focus on pacritinib. Onco Targets Ther. 2016; 9:2655-65. View in: PubMed

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults. Ther Clin Risk Manag. 2016; 12:1301-10. View in: PubMed

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2015 Oct; 15(10):606-11. View in: PubMed

An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians. Korean J Fam Med. 2015 Sep; 36(5):197-202. View in: PubMed

Management of immune-mediated cytopenias in pregnancy. Autoimmun Rev. 2015 Sep; 14(9):806-11. View in: PubMed

Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades. Clin Lymphoma Myeloma Leuk. 2015 Jul; 15(7):409-415. e1. View in: PubMed

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2015 Jun 19. View in: PubMed

Thrombocytopenia: optimizing approaches in cancer patients. Oncology (Williston Park). 2015 Apr; 29(4):297-8. View in: PubMed

Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades. Clin Lymphoma Myeloma Leuk. 2015 Mar 5. View in: PubMed

Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia. Case Rep Pathol. 2015; 2015:594970. View in: PubMed

Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection. Int J Prev Med. 2014 Dec; 5(Suppl 3):S179-S192. View in: PubMed

Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection. Int J Prev Med. 2014 Dec; 5(Suppl 3):S179-92. View in: PubMed

Chronic myelogenous leukemia, version 1. 2015. J Natl Compr Canc Netw. 2014 Nov; 12(11):1590-610. View in: PubMed

Reversible bone marrow aplasia induced by pegylated interferon-a-2a therapy in a patient with primary myelofibrosis. J Oncol Pharm Pract. 2014 Oct; 20(5):386-92. View in: PubMed

Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia. J Natl Compr Canc Netw. 2014 Jul; 12(7):963-8. View in: PubMed

A primary care approach to myelodysplastic syndromes. Korean J Fam Med. 2014 May; 35(3):111-8. View in: PubMed

Visual problem and low back pain as initial manifestation of multiple myeloma complicating pre-existing systemic sclerosis. J Coll Physicians Surg Pak. 2014 Mar; 24 Suppl 1:S29-31. View in: PubMed

Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages? Clin Lymphoma Myeloma Leuk. Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages? Clin Lymphoma Myeloma Leuk. 2014 Feb; 14(1):e19-23. View in: PubMed

Felty's Syndrome, Insights and Updates. Open Rheumatol J. 2014; 8:129-36. View in: PubMed

Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biol Ther. 2013 Dec; 14(12):1077-88. View in: PubMed

Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths. Mediterr J Hematol Infect Dis. 2013 Nov 04; 5(1):e2013068. View in: PubMed

Chronic Myelogenous Leukemia, Version 1. 2014. J Natl Compr Canc Netw. 2013 Nov; 11(11):1327-40. View in: PubMed

Chronic myelogenous leukemia, version 1. 2014. J Natl Compr Canc Netw. 2013 Nov 1; 11(11):1327-40. View in: PubMed

Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new. Autoimmun Rev. 2013 May; 12(7):784-91. View in: PubMed

Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biol Blood Marrow Transplant. 2013 Mar; 19(3):460-7. View in: PubMed

A case of type B lactic acidosis in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2013 Feb; 13(1):80-2. View in: PubMed

Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths. Mediterr J Hematol Infect Dis. 2013; 5(1):e2013068. View in: PubMed

Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report. J Oncol Pharm Pract. 2012 Dec; 18(4):440-4. View in: PubMed

Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012 Dec; 14(6):E161-5. View in: PubMed

Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2012 Jan; 10(1):64-110. View in: PubMed

Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature. Case Rep Hematol. 2012; 2012:207537. View in: PubMed

Revisiting use of growth factors in myelodysplastic syndromes. Asian Pac J Cancer Prev. 2012; 13(4):1081-91. View in: PubMed

Hematologic toxicities of small molecule tyrosine kinase inhibitors. Target Oncol. 2011 Dec; 6(4):203-15. View in: PubMed

Hematologic toxicities associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2011 Nov; 11(11):1663-7. View in: PubMed

When to treat myelodysplastic syndromes. Oncology (Williston Park). 2011 May; 25(6):480-6. View in: PubMed

Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun Rev. 2011 May; 10(7):432-7. View in: PubMed

Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion. 2010 Nov; 50(11):2424-31. View in: PubMed

Howell-Jolly body-like inclusions in neutrophils. Blood. 2009 Oct 01; 114(14):2860. View in: PubMed

Howell-Jolly body-like inclusions in neutrophils. Blood. 2009 Oct 1; 114(14):2860. View in: PubMed

Autoimmune neutropenia in adults. Autoimmun Rev. 2009 Sep; 9(1):62-6. View in: PubMed

Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy. 2009 Jul; 1(4):599-621. View in: PubMed

Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). J Immunother. 2009 Apr; 32(3):322-4. View in: PubMed

Howell-Jolly bodies in patients with chronic GVHD. Blood. 2009 Mar 05; 113(10):2125. View in: PubMed

Howell-Jolly bodies in patients with chronic GVHD. Blood. 2009 Mar 5; 113(10):2125. View in: PubMed

Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Bone Marrow Transplant. 2009 Jan; 43(2):155-8. View in: PubMed

Biology of breast cancer bone metastasis. Cancer Biol Ther. 2008 Jan; 7(1):3-9. View in: PubMed

Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant. 2007 Oct; 40(8):747-52. View in: PubMed

Targeting TGFbeta signaling for cancer therapy. Cancer Biol Ther. 2005 Mar; 4(3):261-6. View in: PubMed

Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol. 1998 Mar; 100(4):773-6. View in: PubMed

The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. Am J Hum Genet. 1997 Jul; 61(1):143-50. View in: PubMed

Powered bySC CTSI